SCHEMBL7257443

SCHEMBL7257443

CC(=O)OC[C@@H]1C[C@@H](OC(C)=O)[C@H](n2cnc3c(=O)[nH]c(N)nc32)O1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HINT1 P49773 5/20 0.54
▸ GSK3A P49840 2/20 0.51
▸ RPS6KA3 P51812 2/20 0.51
▸ MAPK14 Q16539 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.49
▸ NT5E P21589 1/20 0.47
▸ FUT5 Q11128 1/20 0.47
▸ PNP P00491 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ TLR7 Q9NYK1 1/20 0.45
▸ STING1 Q86WV6 2/20 0.45
▸ PDE3B Q13370 1/20 0.45
▸ PDE3A Q14432 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18759054 1.00 HINT1 (0.54) HINT1GSK3ARPS6KA3MAPK14ALDH1A1
SCHEMBL25711923 0.92 HINT1 (0.50) HINT1GSK3ARPS6KA3MAPK14NT5E
SCHEMBL24680699 0.88 HINT1 (0.54) HINT1GSK3ARPS6KA3MAPK14ALDH1A1
SCHEMBL18759058 0.87 ALDH1A1 (0.43) HINT1GSK3ARPS6KA3MAPK14ALDH1A1
SCHEMBL7253950 0.86 TYMP (0.49) HINT1GSK3ARPS6KA3MAPK14NT5E
SCHEMBL7253951 0.86 TYMP (0.49) HINT1GSK3ARPS6KA3MAPK14NT5E
SCHEMBL3893075 0.84 POLB (0.54) HINT1GSK3ARPS6KA3MAPK14ALDH1A1
SCHEMBL18769456 0.84 POLB (0.54) HINT1GSK3ARPS6KA3MAPK14ALDH1A1
SCHEMBL2775081 0.84 POLB (0.54) HINT1GSK3ARPS6KA3MAPK14ALDH1A1
SCHEMBL23352540 0.84 POLB (0.54) HINT1GSK3ARPS6KA3MAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051881-A1 SUBSTITUTED PURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS BY SOLID-PHASE COMBINATORIAL STRATEGIES RIBAPHARM INC. (US) 2003-06-26 — — WO disclosed
Send feedback